Become an early investor in ZOLES – before we open to the public

We are now opening for a small group to indicate interest in becoming co-owners of ZOLES before we launch our public investment round in autumn 2026 via Republic Europe.

35
milliarder
Market size in DKK
7
%
annual industry growth
11.000
+
Danish customers

The mission. The market. The journey.

For the first time, you can be confident that your insoles make a real difference.

Millions of people in Europe live with pain in their feet, knees, and back—often without knowing the biomechanical cause. They adapt to the symptoms but lack insight into how their body actually moves.

ZOLES was founded with a clear ambition: to make biomechanical insight and personalised movement analysis digitally accessible—not only through specialist clinics.

We started with custom-designed insoles as our first commercial product.
But the insole is not the end goal—it is the gateway to a scalable digital platform for movement health.

Today, we operate a health-tech solution that combines mobile 3D scanning, automated analysis, and digital production. The technology is developed, the business model is validated, and we have built a customer base with proven loyalty.
The market for orthopaedic solutions and preventive movement health is worth billions and is growing structurally, driven by an ageing population, increased focus on an active lifestyle, and the digitalisation of healthcare.

We are now at a strategic crossroads: should we continue with organic growth—or accelerate and position ZOLES strongly in the European market?

We choose to build something bigger

We have chosen the latter, and therefore we are raising min. €200,000 via Republic Europe. The capital will be used to enter the UK market, improve the online platform, and prepare for the next growth phase.

We are not just building a product. We are building a scalable digital health platform.

As a co-investor, you become part of that journey—not only as a customer, but as a co-owner of a platform built to scale and evolve over time. An ambition to create something that reaches far beyond the product alone.

Learn more

About ZOLES®

ZOLES is a Danish health-tech company with Cecilie Lisberg as co-founder and CEO. We develop personalised insoles based on digital 3D scanning and online AI-driven health consultation on feet and biomechanics. The insoles are 3D-printed in Denmark as made-to-order production with no waste. ZOLES follows the EU guidelines for Custom Made Medical Products and is registered with the Danish Medicines Agency. Our fully automated, scalable production makes it possible to deliver a quality product efficiently and cost-effectively.

  • 11,000+ paying customers in Denmark
  • DKK 1.5 million in revenue in 2025
  • Validated product with high customer loyalty.
  • Scalable growth strategy towards 2030.
Read more about our technology

Equity crowdfunding means that private investors can invest in growth companies in exchange for receiving ownership stakes (shares).

Instead of one large investor, multiple investors invest collectively via a regulated platform.

Our campaign will be conducted via Republic Europe, one of Europe’s leading equity crowdfunding platforms.

We believe the health-tech of the future should be built with the community—not behind closed doors.

Equity crowdfunding gives those who believe in the product the opportunity to become co-owners. At the same time, Republic Europe ensures:

  • A regulated investment structure

  • Professional nominee model (one consolidated investor line in the share register)

  • Institutional-grade documentation

Investing in early-stage growth companies involves risk, and there is no guarantee of returns. It is realistic to expect that any potential return may be several years in the future.

ZOLES operates in a multi-billion market that is growing by approx. 7% annually. Our ambition is to build a scalable health-tech platform with the potential for a strategic exit within approx. 5 years. There is no guarantee—but there is a clear direction and growth plan.

The capital will be used to accelerate the development of our platform, strengthen the technology, and expand our market position.

With €100,000 invested, we focus on stable growth in Denmark and England. (100% marketing)
With €300,000 invested, we can accelerate growth and international scaling, as well as improve our technology and platform. (25% development, 75% marketing)

The funds will be used for growth—not to repay debt.

ZOLES is currently run by a dedicated team with strong product and market understanding, with 11,000 customers behind us.

To accelerate growth, we need to strengthen the organisation with:

  • Additional development resources within software and platform
  • A CRM and marketing profile that can scale the customer journey and our digital presence

The capital raise will, among other things, make it possible to build these capabilities and take the company to the next level.

No. When you complete the form, you are only indicating interest.
You are not legally committing to invest.

When the campaign goes live on Republic Europe, you will be able to review all details before making a final decision.

If the minimum target is not reached, the investment will not be completed and no funds will be collected.

An investment in ZOLES is an investment in an ambitious health-tech company with an international direction.

We do not expect to pay dividends in the first years, as earnings will be reinvested in growth, technology, and market position.

Our ambition is to build a strong European brand with global potential within digital foot scanning and biomechanical insight. The strategy is to scale the company with a view to a possible strategic exit within approx. 5 years.

If we succeed in realising that ambition, the value at an exit could be significantly higher than the original investment.

In addition to the opportunity to achieve a substantial return on your stake in ZOLES at an exit, as a co-owner of ZOLES you will receive:

  • access to ongoing updates
  • the opportunity to influence the growth direction
  • early access to new features, events, and products
  • exclusive investor benefits when purchasing ZOLES insoles. The larger your investment, the more gift cards you receive each year.

You will learn more specific benefits by June 2026.

Join our pre-launch investor group

Complete the form below if you would like to receive information about ZOLES’ upcoming capital raise on Republic Europe.
Select the investment range that best matches your current considerations. The expression of interest and the amount are indicative and entirely non-binding. The final investment will only take place once all terms have been published on the platform.

What happens when I sign up?

When you register your interest, you become part of our closed pre-launch investor group.

You can then expect:

  • A personal follow-up email from co-founder Cecilie in week 34 with next steps.
  • Access to additional investor material.
  • Invitations to online and in-person events this fall
  • An invitation to invest when the campaign goes live on the crowdfunding platform.

Meet ZOLES – Live investor introduction

Join our 30-minute online session and hear about ZOLES—and how you can invest in the upcoming Crowdfunding campaign. There will be plenty of time for questions. You will receive an invitation once you have submitted an indication of interest.

– Wednesday 9 September at 16.30
– Thursday 10 October at 19.30

I invest in ZOLES because they challenge a traditional industry with technology. Their digital solution, where you can scan your feet via your mobile and get 3D-printed insoles made specifically for your foot, makes the product far more accessible and scalable.

Thomas Visti